A Randomized, Double-blind, Placebo Controlled Trial to Assess the Efficacy of Neridronate 100 mg -4 i.v. Infusions- in Patients With Painful Osteoarthritis of the Knee With Bone Marrow Lesions.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Neridronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 08 Mar 2013 New trial record
- 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.